Cisco Systems San Jose, CA Dec 2012 to Oct 2013 Sr. Software EngineeriPhone and Android
Oct 2009 to Nov 2012 Co-founder, Director of Product Marketing, VP of business developmentFujitsu Network Communications Sunnyvale, CA 2008 to 2009 Sr. Software EngineerBEA Systems San Jose, CA 2007 to 2007 Customer Relationship EngineerPrudential Financial East Hanover, NJ 2005 to 2006 Sr. Java ProgrammerAT&T Research Labs Middletown, NJ 2002 to 2004 Sr. Software EngineerLucent Technology Middletown, NJ 2000 to 2001 Software EngineerEDS Corp Bedminster, NJ Jul 1997 to Feb 2000 System Analyst
Education:
Huazhong University of Science and Technology Las Vegas, NV 1997 Bachelor of Engineering in Computer Science and Engineering DepartmentUniversity of Houston Houston, TX MS in Computer Science
Name / Title
Company / Classification
Phones & Addresses
Jane Chen Vice President-finance And Administration
New York School-Interior Dszn Colleges, Universities, and Professional Scho...
170 E 70Th St, New York, NY 10021
Jane Chen President
Chen, Jane News Dealers and Newsstands
67 East 3Rd Street, New York, NY 10003
Jane Chen President
Nydeco Whol Homefurnishings
385 Bayview Ave, Amityville, NY 11701 (631)8412308
Jane Chang Chen Director, President, Secretary, Treasurer
Jp Creative Laboratory, Inc Business Services at Non-Commercial Site · Nonclassifiable Establishments · Trust Management
10680 SW 40 Mnr, Fort Lauderdale, FL 33328
Jane Chen Vice President-finance And Administration
New York School-Interior Dszn
170 E 70 St, New York, NY 10021 (212)4721500, (212)4723800
The present invention relates to novel prodrugs of gabapentin and to pharmaceutical formulations and sustained release formulations containing the prodrugs.
Controlled Release Formulation Of Captopril Or A Prodrug Of Captopril
Chih-Ming Chen - Cooper City FL Jane Chang Chen - Cooper City FL Elliot Hahn - North Miami Beach FL
Assignee:
Andrx Pharmaceuticals Inc. - Fort Lauderdale FL
International Classification:
A61K 922 A61K 928 A61K 952
US Classification:
424481
Abstract:
The invention provides a controlled release pharmaceutical unit dose composition for oral administration which comprises: (a) an internal phase which comprises captopril or a prodrug of captopril in admixture with a hydrogel forming agent; and (b) an external phase which comprises a coating which resists dissolution in the stomach.
Other authors include Seahyung Park, Mao Ye, Sukjae Kang, Jinho Jhang, Joan Vaughan, and Alan Saghatelian of Salk; Sekun Park, Jane Chen, Avery Hunker, Larry Zweifel, and Richard Palmiter of University of Washington; and Kathleen Caron of University of North Carolina at Chapel Hill.